SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-15-000954
Filing Date
2015-03-23
Accepted
2015-03-23 06:07:30
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1354918
2 ex31-1.htm EX-31.1 20967
3 ex31-2.htm EX-31.2 21951
4 ex32-1.htm EX-32.1 8582
5 ex32-2.htm EX-32.2 8821
  Complete submission text file 0001493152-15-000954.txt   7842707

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE aker-20141231.xml EX-101.INS 963135
7 XBRL SCHEMA FILE aker-20141231.xsd EX-101.SCH 69073
8 XBRL CALCULATION FILE aker-20141231_cal.xml EX-101.CAL 85533
9 XBRL DEFINITION FILE aker-20141231_def.xml EX-101.DEF 249708
10 XBRL LABEL FILE aker-20141231_lab.xml EX-101.LAB 488008
11 XBRL PRESENTATION FILE aker-20141231_pre.xml EX-101.PRE 377166
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-36268 | Film No.: 15717611
SIC: 2835 In Vitro & In Vivo Diagnostic Substances